Nosocomial infection by sequence type 357 multidrug-resistant acinetobacter baumannii isolates in a neonatal intensive care unit in Daejeon, Korea

Annals of Laboratory Medicine

Volumn 33, Issue 4, 2013, Pages 279-282

  Sung, Ji Youn ^a   Koo, Sun Hoe ^a,b,c   Cho, Hye Hyun ^c,d   Kwon, Kye Chul ^a,b  

^a Department of Biomedical Laboratory Science ^*  (South Korea)

^b Far East University   (South Korea)

^c Chungnam National University College of Medicine   (South Korea)

^d Jeonju Kijeon College   (South Korea)

Author keywords

Acinetobacter baumannii; Carbapenem; Neonatal intensive care unit; Nosocomial infection

Indexed keywords

EID: 84880367383     PISSN: 22343806     EISSN: 22343814     Source Type: Journal    
DOI: 10.3343/alm.2013.33.4.279     Document Type: Article

References (16)

1. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008;21:538-82.
2. Wisplinghoff H, Edmond MB, Pfaller MA, Jones RN, Wenzel RP, Seifert H. Nosocomial bloodstream infections caused by Acinetobacter species in United States hospitals: clinical features, molecular epidemiology, and antimicrobial susceptibility. Clin Infect Dis 2000;31:690-7.
3. Villegas MV and Hartstein AI. Acinetobacter outbreaks, 1977-2000. Infect Control Hosp Epidemiol 2003;24:284-95.
4. Garnacho-Montero J, Ortiz-Leyba C, Fernandez-Hinojosa E. Aldabo-Pallas T, Cayuela A, Marguez-Vacaro JA, et al. Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings. Intensive Care Med 2005;31:649-55.
5. Touati A, Achour W, Cherif A, Hmida HB, Afif FB, Jabnoun S, et al. Outbreak of Acinetobacter baumannii in a neonatal intensive care unit: antimicrobial susceptibility and genotyping analysis. Ann Epidemiol 2009; 19:372-8.
6. Gundi VA, Dijkshoom L, Burignat S, Raoult D, La Scola B. Validation of partial rpoB gene sequence analysis for the identification of clinically important and emerging Acinetobacter species. Microbiology 2009;155: 2333-41.
7. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Fifteenth Informational supplement, M100-S20. Wayne, PA: Clinical and Laboratory Standards Institute, 2010.
8. Turton JF, Gabriel SN, Valderrey C, Kaufmann ME, Pitt TL. Use of sequence-based typing and multiplex PCR to identify clonal lineages of outbreak strains of Acinetobacter baumannii. Clin Microbiol Infect 2007; 13:807-15.
9. Bartual SG, Seifert H, Hippler C, Luzon MA, Wisplinghoff H, Rodriguez-Valera F. Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J Clin Microbiol 2005;43:4382-90.
10. Bou G, Cervero G, Dominguez MA, Quereda C, Martinez-Beltran J. PCR-based DNA fingerprinting (REP-PCR, AP-PCR) and pulsed-field gel electrophoresis characterization of a nosocomial outbreak caused by imipenem-and meropenem-resistant Acinetobacter baumannii. Clin Microbiol Infect 2000;6:635-43.
11. Koo SH, Kwon KC, Cho HH, Sung JY. Genetic basis of multidrug-resistant Acinetobacter baumannii clinical isolates from three university hospitals in Chungcheong Province, Korea. Korean J Lab Med 2010;30:498-506.
12. Cho YJ, Moon DC, Jin JS, Choi CH, Lee YC, Lee JC. Genetic basis of resistance to aminoglycosides in Acinetobacter spp. and spread of armA in Acinetobacter baumannii sequence group 1 in Korean hospitals. Diagn Microbiol Infect Dis 2009;64:185-90.
13. Zhou Y, Yu H, Guo Q, Xu X, Ye X, Wu S, et al. Distribution of 16S rRNA methylases among different species of Gram-negative bacilli with highlevel resistance to aminoglycosides. Eur J Clin Microbiol Infect Dis 2010; 29:1349-53.
14. Akasaka T, Tanaka M, Yamaguchi A, Sato K. Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance. Antimicrob Agents Chemother 2001;45: 2263-8.
15. Valentine SC, Contreras D, Tan S, Real LJ, Chu S, Xu HH. Phenotypic and molecular characterization of Acinetobacter baumannii clinical isolates from nosocomial outbreaks in Los Angeles County, California. J Clin Microbiol 2008;46:2499-507.
16. McGrath EJ, Chopra T, Abdel-Haq N, Preney K, Koo W, Asmar BI, et al. An outbreak of carbapenem-resistant Acinetobacter baumannii infection in a neonatal intensive care unit: investigation and control. Infect Control Hosp Epidemiol 2011;32:34-41.